Stay updated on Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:37:31.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:50.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:27.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the Results section, replacing 'No Results Posted'. This indicates that trial results are in progress and awaiting posting.
    Difference
    0.1%
    Check dated 2026-02-18T16:25:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the funding-lapse notice along with Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:00:31.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:30:05.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.